Daily XZK 1200mg and 2400mg for 4 to 12weeks resulted in statistically significant ( P < .001 ) and clinically meaningful decreases in non-HDL-C ( 24 % reduction ) and LDL-C ( 27 % reduction ) compared with placebo .